Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biotech
boston blog main
boston top stories
boulder/denver blog main
boulder/denver top stories
detroit blog main
detroit top stories
indiana blog main
4
×
indiana top stories
life sciences
national
4
×
national blog main
national top stories
new york blog main
new york top stories
raleigh-durham blog main
raleigh-durham top stories
san diego blog main
san diego top stories
san francisco blog main
san francisco top stories
seattle blog main
seattle top stories
texas blog main
texas top stories
wisconsin blog main
wisconsin top stories
4
×
cancer
novartis
accent therapeutics
alexion pharmaceuticals
amgen
asklepios biopharmaceutical
bridgebio
fda
investing
ipo
medical devices
opioids
pfizer
What
new
4
×
bio
roundup
drug
drugs
activity
advantages
approvals
bails
bar
biogen
brand
bridgebio
brings
capital
car
cholesterol
clamped
covid
delays
develop
developing
economic
emerges
expect
expensive
faces
fast
fda
financial
firm
foe
gamble
grab
headlines
healthcare
hint
ichnos
including
inhibitors
Language
unset
4
×
Current search:
national
×
new
×
" indiana blog main "
×
" wisconsin top stories "
×
unset
×
@xconomy.com
4 years ago
Bio Roundup: Fast FDA Approvals, Biogen Delays, ORIC’s IPO & More
@xconomy.com
4 years ago
Bio Roundup: Ichnos Emerges, Beyond CAR-T, BridgeBio Bails & More
@xconomy.com
4 years ago
Bio Roundup: MedCo’s Pricing Plan, Vertex’s Gamble, uBiome Undone
@xconomy.com
4 years ago
New PCSK9 Cholesterol Drug Faces Tough Foe. (Hint: Not Cholesterol.)
